Detalhe da pesquisa
1.
Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis.
Pain Med
; 24(3): 341-350, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102822
2.
Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.
Curr Ther Res Clin Exp
; 98: 100694, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875317
3.
First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
J Emerg Med
; 62(2): 231-239, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893381
4.
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
J Urol
; 206(1): 52-61, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634707
5.
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
Support Care Cancer
; 29(9): 5209-5218, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629189
6.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31742767
7.
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.
Prostate
; 79(6): 604-613, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663074
8.
Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
Pain Pract
; 17(6): 820-828, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27860208
10.
Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials.
J Pain Res
; 16: 395-406, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36798078
11.
Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose.
J Pain Res
; 16: 2595-2607, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533563
12.
Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.
J Pain Res
; 16: 3529-3543, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881233
13.
Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma.
Endocr Relat Cancer
; 30(2)2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472300
14.
Sex and race differences in urinary Tumor Necrosis Factor-α (TNF-α) levels: Secondary analysis of the DASH-sodium trial.
J Hum Hypertens
; 37(8): 701-708, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36008598
15.
Methylnaltrexone for opioid-induced constipation in advanced illness.
N Engl J Med
; 358(22): 2332-43, 2008 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18509120
16.
Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials.
Dis Colon Rectum
; 54(5): 570-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21471758
17.
Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.
J Infect Dis
; 201(10): 1481-7, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20377413
18.
The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation.
Drugs Aging
; 38(6): 503-511, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33788162
19.
Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.
F1000Res
; 10: 891, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34631030
20.
Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies.
J Pain Res
; 14: 2687-2697, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34512008